Showing 851-860 of 4010 results for "".
Earlier Action, Lasting Impact: Closing the LDL-C Gap in Patients Without a Prior MACE
https://reachmd.com/programs/cme/earlier-action-lasting-impact-closing-the-ldl-c-gap-in-patients-without-a-prior-mace/39957/Experts review strategies for aggressive LDL lowering in high-risk patients without prior MI or stroke, highlighting updated targets and VESALIUS-CV data.The Future of HNSCC: Aligning Teams, Transforming Care
https://reachmd.com/programs/cme/The-Future-of-HNSCC-Aligning-Teams-Transforming-Care/54394/Practice-changing data in resectable HNSCC? Experts unpack KEYNOTE-689, NIVOPOSTOP, and how to implement perioperative immunotherapy.Current Updates on Squamous Cell Cancer of the Head and Neck (SCCHN)
https://reachmd.com/programs/global-oncology-academy/current-updates-on-squamous-cell-cancer-of-the-head-and-neck-scchn/8582/Join Jan B. Vermorken, MD, PhD as he shares some of the exciting updates on Squamous Cell Cancer of the Head & Neck (SCCHN).Empowering Epilepsy Care: Opportunities for Neurologists and Pediatricians in Managing Rare Epilepsy Syndromes
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/empowering-epilepsy-care-opportunities-for-neurologists-and-pediatricians-in-managing-rare-epilepsy-syndromes-1/32193/Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
https://reachmd.com/programs/cme/driving-progress-in-cardiology-exploring-the-role-of-fxi-in-acute-coronary-syndromes-beyond/32980/Don’t miss this broadcast replay on the potential role of factor XI inhibition in acute coronary syndrome, Afib, and secondary stroke prevention.Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
https://reachmd.com/programs/project-oncology/reducing-patient-time-burden-in-her2-breast-cancer-with-subcutaneous-trastuzumabpertuzumab/32996/A time and motion substudy within the ADEPT trial demonstrates that subcutaneous administration of trastuzumab and pertuzumab significantly reduces treatment time compared to intravenous delivery in patients with early-stage HER2-positive breast cancer. These time savings could help enhance patientPictorial Eczema Education Shows Promise for Improving Patients’ Quality of Life
https://reachmd.com/programs/dermconsult/pictorial-eczema-education-shows-promise-for-improving-patients-quality-of-life/36438/Pediatric RSV Hospitalizations Reveal Shifting Risk Profiles Post-Pandemic
https://reachmd.com/programs/clinicians-roundtable/pediatric-rsv-hospitalizations-reveal-shifting-risk-profiles-post-pandemic/37134/FA hiPSCs in Translational Drug Development
https://reachmd.com/programs/neurofrontiers/fa-hipscs-translational-drug-development/54667/Best Contact Lens Strategies of 2025
https://reachmd.com/programs/modern-optometry/best-contact-lens-strategies-of-2025/39996/